Harvard Scientific (HVSF)Hot$$- male impotency medicine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gabor who wrote (3158)	2/7/1998 9:16:00 PM
From: RT	Read Replies (1) of 3906

Gabor, -NONE- and proud of it. After doing my DD on HVSF, I cannot see any merits to owning stock in this company.. This Company has: 1. Questionable Management 2. Unbelievable Financing 3. NO Employees 4. NO Marketable Product 5. NO Delivery System (Vivus has that already under patent) Plus 100M to litigate. Incidently, they have already successfully defended their transurethrial patent in the past.. Vivus is already into phase III trials of their improved combo formulations for Muse. Has anyone inquired management on how soon they expect to bring their product to market? I'll bet it will be two years minimum. By then Vivus will be selling SUPERMUSE IV. RT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next